CLINICAL_TRIALS
trial_result
· 2011-06-02
Clinical Trial Update: Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients [Phase 2, Phase 3]
Summary
A double-blind trial in pediatric patients comparing Alacramyn to placebo for scorpion sting envenomation has completed Phase 2 and Phase 3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Instituto Bioclon S.A. de C.V. | Conditions: Scorpion Sting Envenomation | Phase 2, Phase 3 | Status: COMPLETED